Palau Science & Technology Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Palau Science & Technology Journal.

Press releases published on October 20, 2026

Oct. 20, 2026

PageUp Launches Candidate Agent at HR Tech 2026

Indeterminate GlobeNewswire

Oct. 20, 2026

HumaniCore AI Debuts Independent Audits and Certification Standard for AI-Enabled People Decisions

Indeterminate GlobeNewswire

Oct. 20, 2026

Gecko Robotics’ Contract More than Quadruples to $300 Million to Support U.S. Navy Readiness

Indeterminate GlobeNewswire

Oct. 20, 2026

ERGO NEXT Insurance Recognized as a 2026 Inc. Power Partner Award Winner

Indeterminate GlobeNewswire

Oct. 20, 2026

ChartHop expands organizational intelligence beyond HR data, connecting the business to the people who run it

Indeterminate GlobeNewswire

Oct. 20, 2026

Odyssey Therapeutics Presents Completed Phase 2a OD-001 Induction Results Strengthening Clinical Proof of Concept at UEG Week 2026

Indeterminate GlobeNewswire

Oct. 20, 2026

Visara Secures Exclusive Option for Potential Acquisition of YOL104-2 for Ocular Surface Squamous Neoplasia

Indeterminate GlobeNewswire

Oct. 20, 2026

Slate Medicines Strengthens Board of Directors with Appointment of Stephen K. Brannan, MD, and John D. Young

Indeterminate GlobeNewswire

Oct. 20, 2026

Dr. Peter Shor Anchors Prominent Group of Quantum Scientists Joining Zapata’s Advisory Board

Indeterminate GlobeNewswire

Oct. 20, 2026

Abiologics Appoints Per Jr. Greisen as Chief Artificial Intelligence Officer

Indeterminate GlobeNewswire

Oct. 20, 2026

Matternet Expands NHS Drone Delivery Network to Great Ormond Street Hospital

Indeterminate GlobeNewswire

Oct. 20, 2026

Alternative Ballistics Corporation (OTCQB: ALBC) Announces New Purchase Orders from U.S. Retailer Botach and a New Abu Dhabi Distributor

Indeterminate GlobeNewswire

Oct. 20, 2026

BioNTech veröffentlicht am 3. November 2026 Ergebnisse für das dritte Quartal 2026 und informiert über operativen Fortschritt

Indeterminate GlobeNewswire

Oct. 20, 2026

BioNTech to Report Third Quarter 2026 Financial Results and Corporate Update on November 3, 2026

Indeterminate GlobeNewswire

Oct. 20, 2026

Quoin Pharmaceuticals Announces Publication of Peer-Reviewed Paper on QRX003 for Netherton Syndrome in Dermatology and Therapy

Indeterminate GlobeNewswire

Oct. 20, 2026

Leads Biolabs' Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Advances to Expansion Stage in Phase II First-Line Gastric Cancer Study

Indeterminate GlobeNewswire

Oct. 20, 2026

Re $65M Capital Deployment & Executive Appointments

Indeterminate GlobeNewswire

Oct. 20, 2026

VisionWave Advances Development-Stage RF Sensing Portfolio for Counter-UAS, Electronic Warfare and Non-Line-of-Sight Applications

Indeterminate GlobeNewswire

Oct. 20, 2026

Rapport Therapeutics Announces Positive Topline Results from its Phase 2 Trial of RAP-219 for the Treatment of Bipolar Mania

Indeterminate GlobeNewswire

Oct. 20, 2026

Sabre Cybersecurity Warns Ohio Businesses That Ransomware Attacks Strike When Nobody Is Watching

Indeterminate GlobeNewswire